Abzena is a bioconjugate- and biologics-focused CDMO that pushes development of novel treatments forward at every stage from discovery through commercial launch. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their investments in human health. The company has research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK
|
|
|
201-500 employees
View all Abzena employees
|
|
Biotechnology
|
|
6325 Lusk Blvd, San Diego, California 92121, US
|
|
2018
|
|
Process Development, Technology Transfer, Custom Chemical Synthesis, Technology Transfer, Analytical Method Development, Analytical Method Development, Process Development, Pre-Formulation, Pré-Formulation, Adcs & Gmp Bioconjugation, Cell Line Development To Gmp Manufacturing, Immunogenicity Assessment & Protein Engineering, Custom Chemical Synthesis, Analytical And Bioassay Solutions
|
The decision makers in Abzena are Daniel Giroux, Debra Harris, Elonne Petrin, etc. Click to Find Abzena decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.